YOU ARE HERE: LAT HomeCollectionsHpv


May 10, 2007 | Thomas H. Maugh II and Jia-Rui Chong, Times Staff Writers
New data on the controversial HPV vaccine designed to prevent cervical cancer have raised serious questions about its efficacy, researchers reported today, potentially undercutting the efforts in many states to make vaccination mandatory. Although the vaccine, called Gardasil, blocked about 100% of infections by the two human papilloma virus strains it targets, it reduced the incidence of cancer precursors by only 17% overall.
April 4, 2007 | From Times Wire Reports
Democratic Gov. Bill Richardson said in Santa Fe that he would veto a bill that would have required New Mexico girls entering sixth grade to be vaccinated against a sexually transmitted virus that can cause cervical cancer. Richardson had indicated he would sign the bill after it passed the Legislature last month. He said he changed his mind after parents and doctors told him their concerns about the program.
February 5, 1989 | CARRIE FIGDOR, Associated Press
A study of women with radically different sex lives--prostitutes and monogamous Indians--has found new evidence linking promiscuity to transmission of a virus that can cause cervical cancer. Dr. Jose Azocar compared pap smear samples from the prostitutes with those of Piaroa women, part of a strictly monogamous group living in villages scattered in this South American nation's Amazon jungle.
January 30, 2012 | By Amina Khan, Los Angeles Times / For the Booster Shots blog
HPV infects the mouths of an estimated 7% of men and women from the ages of 14 to 69 in the U.S. -- and men have it at higher rates than women, according to a study out last week in the Journal of the American Medical Assn. Just 3.6% of women studied for the paper had oral HPV, while 10.1% of men did. It's unclear why there's such a difference in infection rates, but it may have to do with oral sex practices, experts say. (The Centers for Disease Control and Prevention provides some information specifically related to HPV and men .)
July 9, 2007
My wife had a Pap smear every year of her adult life ["HPV Test or Pap: Understanding the Choices," July 2]. I know, because I was with her since the 11th grade. When doctors found cervical cancer it was stage IVB, no treatment, no cure. She was the "one in a thousand," and died a year later at a too-young 57 years old. If HPV tests had been in use she might have had a chance. Take the test. Even if the results are confusing, as Dr.
October 18, 2007 | Denise Gellene, Times Staff Writer
Using a traditional Pap smear with a relatively new screening test for the virus that causes cervical cancer significantly improves the chances of early detection, according to new research published today. The study of 12,527 women found that the combination of tests detected 51% more cancers and precancerous lesions in initial screenings than the Pap test alone.
December 15, 2011 | By Eryn Brown, Los Angeles Times / for the Booster Shots blog
In a trial involving nearly 40,000 women in the Netherlands, testing for the human papillomavirus, or HPV, allowed doctors to detect abnormal cervical cells earlier -- and prevent more cases of cervical cancer -- than administering pap smears alone.   In the study, which was published Wednesday in the journal Lancet Oncology, a team of researchers led by Dr. Chris J.L.M. Meijer of the VU University Medical Centre in Amsterdam randomly assigned women ages 29-56 into two groups.  The first group received an HPV test as well as a pap smear; the second group, a pap smear alone.  Five years later, both groups had HPV tests and pap smears.
October 25, 2011 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
Despite Republican presidential candidate Michele Bachmann's recent charge that the HPV vaccine can cause "mental retardation," ongoing safety studies on the vaccine reveal no surprises, health officials said Tuesday. "We have no evidence" that HPV vaccination causes mental retardation, said Dr. Eileen Dunne, an epidemiologist at the Centers for Disease Control and Prevention, at a hearing of the Advisory Committee on Immunization Practices, a panel that advises the CDC. The committee voted 13-0 to recommend routine human papillomavirus vaccination for boys ages 11 and 12. The vote included a review of the safety of the vaccine, which has been in use among girls in the United States since 2006.
October 26, 2011 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
The HPV vaccine routinely should be recommended for boys and young men because it clearly cuts the risk of cell changes that can develop into anal cancer, says the author of a study published Wednesday. Data from the paper appearing in the New England Journal of Medicine was presented earlier this year to health authorities who advise the Centers for Disease Control and Prevention on the nation's immunizationstrategy. These experts voted on Tuesday to recommend routine HPV vaccination to boys ages 11 and 12 and catch-up vaccination up to the age of 21. "The study is the first data looking at biomarkers in the development of anal cancer," said Dr. Joel Palefsky, a professor of medicine at UC, San Francisco, and the lead author of the paper.
August 26, 2011 | By Eryn Brown, Los Angeles Times / for the Booster Shots blog
Popular fears about vaccines -- including the belief that the measles, mumps and rubella shot causes autism -- are unfounded, a study released Thursday by the Institute of Medicine reported. But another report released Thursday, from the Centers for Disease Control and Prevention, noted with some alarm that many parents still shun another recommended vaccine: the three-shot series that protects against human papilloma virus (HPV), a widespread sexually transmitted virus, some types of which can cause cervical cancer.
Los Angeles Times Articles